The Australian Business Unit covers the needs of the Australian & New Zealand markets.
Categories
Overseas markets
The Overseas Business Unit was established to develop and grow the presence of Eris Pharmaceuticals in the emerging markets, namely in the Middle East-North Africa (MENA), the Balkans, the CIS, Africa, and the broader Asian markets.
By establishing strategic partnership with local distributors in each market, Eris Pharmaceuticals is nowadays present in more than 25 territories, and plans for further expansion in the coming years.
To find out more about the Overseas Business Unit, its activities and business model, please visit the relevant website.